🧴 RETATRUTIDE – 60 MG KIT (12 MG / VIAL × 5 VIALS) – ZPHC PHARMA

🧪 Product Type

Peptide / Multi-Agonist Hormonal Therapy

Active Ingredient: Retatrutide

Dosage Form: Lyophilized powder for reconstitution

Total Kit Strength: 60 MG

Vial Strength: 12 MG per vial

Package Content: 5 vials per kit

📄 Description

RETATRUTIDE by ZPHC Pharma is a next-generation multi-agonist peptide that targets GLP-1, GIP, and glucagon receptors, making it a highly promising candidate for advanced weight management, metabolic optimization, and type 2 diabetes support.

This formulation is designed for research purposes only, providing insight into how triple agonists can influence appetite regulation, insulin sensitivity, and fat oxidation.

🔹 Product Features

• Concentration: 12 MG of Retatrutide per vial
• Total Dose: 60 MG per kit (5 vials × 12 MG)
• Form: Lyophilized powder – requires reconstitution with bacteriostatic water
• Storage: Store refrigerated (2°C–8°C) after reconstitution
• Purity: Pharmaceutical-grade research peptide

✅ Key Research Benefits

• 🔥 Appetite Suppression: Enhances satiety and reduces caloric intake
• 💪 Fat Loss & Metabolic Boost: Supports thermogenesis and fat breakdown
• 💉 Insulin Sensitivity: Improves glucose uptake and beta-cell function
• 🧪 Triple Receptor Action: Acts simultaneously on GLP-1, GIP & glucagon receptors for comprehensive metabolic modulation

📈 Suggested Research Use (For Investigational Use Only)

Retatrutide is supplied as a lyophilized powder and must be reconstituted with bacteriostatic water before subcutaneous administration.

Dosage, frequency, and duration should be defined according to the parameters of the research protocol.

⚠️ Potential Side Effects (Observed in Research Contexts)

• Nausea or gastrointestinal discomfort
• Reduced appetite
• Mild injection site reactions
• Potential alterations in glucose metabolism

Monitoring is advised during extended study periods.

🚫 Contraindications (Research Advisory)

Not recommended for use in subjects with:

• History of medullary thyroid carcinoma
• Multiple endocrine neoplasia syndrome type 2 (MEN 2)
• Known allergy to peptide-based therapeutics

🛒 Purchase Information

• For Research Purposes Only – Not for Human Consumption
• Supplied as: 60 MG KIT (5 vials × 12 MG)
• Manufacturer: ZPHC PHARMA
• Ensure authenticity and quality by ordering through certified research suppliers
• Shipping Time: Typically 5–12 business days based on location